The occurence of cancer in first admitted schizophrenic patients

[1]  G. Jagetia.  Effect of chlorpromazine hydrochloride on the formation of micronuclei in the bone marrow of mice exposed to gamma radiation. , 2008, Hereditas.

[2]  A. Jablensky,et al.  Cancer Incidence of Schizophrenic Patients Results of Record Linkage Studies in Three Countries , 1992, British Journal of Psychiatry.

[3]  Y. Webb,et al.  A Needs Survey among Patients in Leros Asylum , 1992, British Journal of Psychiatry.

[4]  P. Mortensen,et al.  Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients , 1992, Acta psychiatrica Scandinavica.

[5]  L. Adler,et al.  Concurrent medical illness in the schizophrenic patient Epidemiology, diagnosis, and management , 1991, Schizophrenia Research.

[6]  K. Juel,et al.  Mortality and causes of death in schizophrenic patients in Denmark , 1990, Acta psychiatrica Scandinavica.

[7]  P. Munk-Jørgensen,et al.  Schizophrenia: a 13‐year follow‐up , 1989, Acta psychiatrica Scandinavica.

[8]  N. Zilber,et al.  Mortality among psychiatric patients ‐ the groups at risk , 1989, Acta psychiatrica Scandinavica.

[9]  P. Mortensen,et al.  The incidence of cancer in schizophrenic patients. , 1989, Journal of epidemiology and community health.

[10]  A. Hercbergs.  THIORIDAZINE: A RADIATION ENHANCER IN ADVANCED CERVICAL CANCER? , 1988, The Lancet.

[11]  J. Zacho,et al.  [Changes in the smoking habits of Danes in the period 1970-1987]. , 1988, Ugeskrift for laeger.

[12]  G. T. Budd,et al.  Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Y. Senturia,et al.  The epidemiology of testicular cancer. , 1987, British journal of urology.

[14]  Mortensen Pb.  Diagnosis of cancer and autopsy rate in schizophrenic patients , 1987 .

[15]  P. Boyle,et al.  Cancer of the prostate: epidemiology and aetiology. , 1987, British journal of urology.

[16]  P. Mortensen.  Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients , 1987, Acta psychiatrica Scandinavica.

[17]  P. Munk-Jørgensen.  Why has the incidence of schizophrenia in Danish psychiatric institutions decreased since 1970? , 1987, Acta psychiatrica Scandinavica.

[18]  Jones Gr.  Cancer therapy: phenothiazines in an unexpected role. , 1985 .

[19]  B. O'Shea,et al.  Smoking and Malignancy in Schizophrenia , 1984, British Journal of Psychiatry.

[20]  J. Baldwin.  Schizophrenia and physical disease , 1979, Psychological Medicine.

[21]  H. Meltzer,et al.  Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue. , 1978, Archives of general psychiatry.

[22]  J. Overall.  Prior psychiatric treatment and the development of breast cancer. , 1978, Psychopharmacology bulletin.

[23]  D. Kodlin,et al.  Reserpine and breast cancer , 1978, Cancer.

[24]  C. Müller,et al.  [Cancer mortality in patients of psychiatric hospitals]. , 1977, Schweizerische medizinische Wochenschrift.

[25]  R. Doll,et al.  RAUWOLFIA DERIVATIVES AND BREAST CANCER IN HYPERTENSIVE WOMEN , 1976, The Lancet.

[26]  W. O'Fallon,et al.  RAUWOLFIA DERIVATIVES AND BREAST CANCER , 1975, The Lancet.

[27]  E. Laska,et al.  MATCHED-PAIRS STUDY OF RESERPINE USE AND BREAST CANCER , 1975, The Lancet.

[28]  M. Pike,et al.  Reserpine and breast cancer in a retirement community. , 1975, The New England journal of medicine.

[29]  S. Shapiro,et al.  Reserpine use in relation to breast cancer. , 1974, Lancet.

[30]  R. Doll,et al.  Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. , 1974, Lancet.

[31]  B. H. Fox,et al.  Cancer risk among psychiatric patients: a hypothesis. , 1974, International journal of epidemiology.

[32]  Eicke Wj.  Favorable course in carcinoma patients due to additional phenothiazine therapy , 1973 .

[33]  L. Csatary.  Chlorpromazines and cancer. , 1972, Lancet.

[34]  O. F. Ehrentheil.  Common medical disorders rarely found in psychotic patients. , 1957, A.M.A. archives of neurology and psychiatry.

[35]  A. Scheflen.  Malignant tumors in the institutionalized psychotic population. , 1951, A.M.A. archives of neurology and psychiatry.

[36]  A. Osterlind.  Malignant melanoma in Denmark. Occurrence and risk factors. , 1990, Acta oncologica.

[37]  A. Harris,et al.  Physical disease and schizophrenia. , 1988, Schizophrenia bulletin.

[38]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[39]  A. Jablensky,et al.  Incidence of cancer in patients diagnosed as schizophrenic in Denmark. , 1986 .

[40]  J. Baldwin.  Schizophrenia and physical disease: a preliminary analysis of the data from the Oxford Record Linkage Study , 1980 .

[41]  J. Clemmesen.  Statistical studies in the aetiology of malignant neoplasms. , 1974, Acta pathologica et microbiologica Scandinavica. Supplement.